Loading company…
Tissuetech, Inc. is a Miami-based biotechnology company that develops regenerative healing products using its CryoTek technology.
Tissuetech, Inc. works in regenerative medicine, preserving human birth tissue allografts through its CryoTek technology for use in ophthalmology and surgery. Its products include Prokera, AmnioGraft, AmnioGuard and Neox, sold to hospitals, surgical centers and healthcare practitioners. Founded in 2001 and headquartered in Miami, US, the company raised USD 82.25 mn in Series C funding in April 2019, led by Essex Woodlands, with participation from Ballast Point Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in